Xcout Intel
Applied Pharmaceutical Innovation (API)
Applied Pharmaceutical Innovation is a not-for-profit life sciences commercialization organization that provides contract research, regulatory, clinical, and contract development and manufacturing (CDMO) services to life sciences companies and innovators. It supports the development of pharmaceuticals, biologics, medical devices, and natural health products through fee-for-service support, startup programming, and industry training.
Subscribe to see Applied Pharmaceutical Innovation (API)’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Applied Pharmaceutical Innovation (API) at a glance
Applied Pharmaceutical Innovation (API) is a pharmaceuticals, biotech company headquartered in Canada. Xcout tracks 9 named people at Applied Pharmaceutical Innovation (API), including Andrew MacIsaac (CEO).
Applied Pharmaceutical Innovation (API) leadership
- Andrew MacIsaacCEO
- Launa AspesletChief Translational Officer
- Sir Michael HoughtonChief Scientific Officer
- Allan AginskiSenior VP, Special Projects Manufacturing
- Amy GaucherVP, Shared Services
- Corinne CampanellaVP, Quantitative Solutions
3 more named people on record for Applied Pharmaceutical Innovation (API), with roles, board committees and tenure — see the full roster →
Applied Pharmaceutical Innovation (API) competitors
A few of Applied Pharmaceutical Innovation (API)'s closest competitors — see the full list of competitors and alternatives →
PCI Pharma Services is a global contract development and manufacturing organization (CDMO) that supports biopharmaceutical clients in bringing drug products to market.
Quotient Ltd, operating as Quotient Sciences, is a United Kingdom-based drug development and manufacturing accelerator that provides integrated programs and services across the development pathway.
Sinotherapeutics Inc. is a high-tech pharmaceutical enterprise focused on the research, commercial production, and sales of advanced drug formulations, including anti-infective, anti-tumor, metabolic, and cardiovascular medications. The company also provides innovative drug formulation CRO and CMO services to global patients and pharmaceutical partners.
Medtide Inc. operates as a contract research, development, and manufacturing organization (CRDMO), providing comprehensive services across the entire pharmaceutical lifecycle, from initial drug discovery and preclinical investigation through to clinical development and commercial-scale production. The company specializes in the synthesis of novel peptide chemical entities for discovery purposes, along with the development of peptide-based chemistry, manufacturing, and control (CMC) processes, and their subsequent commercial manufacturing. A core area of its developmental focus is on glucagon-like peptide-1 (GLP-1) molecules, which it designs for both oral and/or injectable administration. Medtide leverages a suite of proprietary research and development platforms, including OmniPeptSynth, PeptiConjuX, PeptiNuclide LinkTech, GreenSynth Innovations, and Impurity Screening. Its client base spans multiple regions globally, including China, the United States, Japan, Europe, South Korea, and Australia. Established in 2020 as Taide Pharmaceutical (Zhejiang) Co., Ltd, the company rebranded to Medtide Inc. in February 2023 and maintains its headquarters in Hangzhou, China.
Sai Life Sciences operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) providing services from drug discovery to manufacturing. It serves pharmaceutical and biotech companies by offering capabilities in synthetic medicinal chemistry, biology, drug metabolism and pharmacokinetics, process development, and drug substance manufacturing.
Get Applied Pharmaceutical Innovation (API)'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Applied Pharmaceutical Innovation (API) in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access